SC
ACHV icon

Steven Cohen’s Achieve Life Sciences ACHV Stock Holding History

Steven Cohen’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-37,760
Closed -$111K – 3930
2026
Q1 		$111K Sell
37,760
-37,409
-50% -$166K ﹤0.01% 3598
2025
Q4 		$374K Buy
+75,169
New +$328K ﹤0.01% 3381

Other funds holding ACHV

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Steven Cohen's ACHV Position: Q2 2026 in Review

Steven Cohen sold out of Achieve Life Sciences (ACHV) in Q2 2026, closing a stake of 37,760 shares — an estimated $111K sold.

Steven Cohen first reported a position in ACHV in Q4 2025 and held it in 2 quarters. The position peaked at $374K in Q4 2025. 110 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • Steven Cohen reported no remaining Achieve Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Steven Cohen sold 37,760 Achieve Life Sciences shares in Q2 2026, an estimated $111K.
  • Steven Cohen first reported a position in Achieve Life Sciences in Q4 2025 and held it in 2 quarters.
  • Steven Cohen's Achieve Life Sciences position peaked at $374K in Q4 2025.
  • 110 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.